Editas Medicine vs VI Therapeutics
Editas Medicine vs VI Therapeutics, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Editas Medicine is on 42/100 and VI Therapeutics on 31/100.
Where each one leads
Editas Medicine
- our overall score: 42/100 against 31/100
- agent readiness: 39/100 against 34/100
VI Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Editas Medicine | VI Therapeutics |
|---|---|---|
| What it is | A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases. | VI Therapeutics is developing novel therapies for rare genetic diseases. |
| Category | Biotech, MedTech, Genomics, Drug Discovery | Life Sciences, Biotech, MedTech, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2013 | 2017 |
| Headquarters | Cambridge, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Editas Medicine | VI Therapeutics |
|---|---|---|
| Employees | 185 | Not published |
| Total funding | $210M | Not published |
| Latest round | Series C | Not published |
| LinkedIn followers | 52,616 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Editas Medicine | VI Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 42/100 | 31/100 |
| Traction | 60/100 | Not published |
| Team | Not published | 30/100 |
| Search visibility | 27/100 | 8/100 |
| Quality | 45/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (34/100) |
| Domain ratingLink authority, 0-100 | 61/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Editas Medicine | VI Therapeutics |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Not detected |
| Analytics | Google Tag Manager | Not detected |
| Open source | No | Yes |
Editas Medicine vs VI Therapeutics: common questions
Which is better, Editas Medicine or VI Therapeutics?
On our 0-100 score Editas Medicine rates higher (42/100 against 31/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do Editas Medicine and VI Therapeutics compare on the numbers?
Editas Medicine leads on our overall score (42/100 against 31/100), agent readiness (39/100 against 34/100).
Read the full Editas Medicine review and pricing or the VI Therapeutics review and pricing. You can also browse other Editas Medicine alternatives we track.